home


April 21, 2014 press releases April 21, 2014

Even though there are more FDA requirements to meet, today Sarepta Therapeutics "announced plans to submit a New Drug Application to the FDA for Eteplirsen for the treatment of Duchenne Muscular Dystrophy by year end 2014." Read more.

Other links with information.
Forbes
Yahoo Finance
UK Reuters
Washington Post
Fox News Interview with Christine McShary & Jenn Mcnary

What this means for Aidan is that he'll likely be able to participate in this trial as Sarepta is taking boys who were in the drisapersen trial.
THIS IS VERY GOOD NEWS!!

Thanks to Mindy, Jenn, Christine, Tracy, and other DMD families who scheduled meetings with scientists and the FDA, and put together The Race to Yes campaign. There will certainly be more to do, but for today, a small celebration is in order!


save the date
9th Annual Run-Walk for Aidan & Runners Reunion
August 30, 2014
See photos from past runs.


 

  





Support Loyal Sponsors

If any of you have photos or stories you'd like
to send for the site, please send them to Judy Schneider